Results 41 to 50 of about 12,455 (266)

Ébola, lo que debemos saber

open access: yesRevista Ciencias Biomédicas, 2020
La entidad conocida como ébola, recibe esa denominación por el nombre del río más cercano al distrito africano, donde se presentaron los primeros casos del brote en la década de los setenta del siglo XX (1).
Comité Editorial
doaj   +1 more source

Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity

open access: yesVirulence, 2021
Ebola virus (EBOV), belonging to the species Zaire ebolavirus in the genus Ebolavirus, causes a severe febrile illness in humans with case fatality rates (CFRs) up to 90%.
Satoko Yamaoka, Hideki Ebihara
doaj   +1 more source

Re-emergence of Sudan ebolavirus after a decade: new challenge to Ebola control

open access: yesInternational Journal of Surgery, 2023
Dear Editor, Outbreaks of African filoviruses often have resulted into high mortality, and of these, the West Africa Ebola outbreak during 2014–2016 accounted for more than 11 000 deaths among around 28 000 cases.
R. Sah   +8 more
semanticscholar   +1 more source

A predictive model of ebolavirus spillover incorporating change in forests and human populations across spatial and temporal scales

open access: yesmedRxiv, 2023
Past research has found associations between ebolavirus spillover and forest loss and fragmentation, although most predictions of the spatial distribution of ebolaviruses have not utilized these data.
C. T. T. Mph   +6 more
semanticscholar   +1 more source

One-Step Reverse-Transcription FRET-PCR for Differential Detection of Five Ebolavirus Species. [PDF]

open access: yesPLoS ONE, 2015
Ebola is an emerging infectious disease caused by a deadly virus belonging to the family Filoviridae, genus Ebolavirus. Based on their geographical distribution, Ebolavirus has been classified into total five species so far, mainly Zaire, Sudan, Taï ...
Guangwu Lu   +6 more
doaj   +1 more source

Lactic acid bacterial surface display of scytovirin inhibitors for anti-ebolavirus infection

open access: yesFrontiers in Microbiology, 2023
Scytovirin (SVN) is a lectin from cyanobacteria which has a strong inhibitory activity against Ebola virus infection. We engineered scytovirin as the inhibitor for surface display of lactic acid bacteria to block Ebola virus infection.
J. Wiggins   +5 more
semanticscholar   +1 more source

Development and validation of portable, field-deployable Ebola virus point-of-encounter diagnostic assay for wildlife surveillance

open access: yesOne Health Outlook, 2021
Early detection of Ebola virus spillover into wildlife is crucial for rapid response. We developed and validated a portable, cold-chain independent Ebola virus RT-qPCR assay.
Dania M. Figueroa   +14 more
doaj   +1 more source

RNA binding motif 4 inhibits the replication of ebolavirus by directly targeting 3′-leader region of genomic RNA [PDF]

open access: goldEmerging Microbes and Infections
Ebola virus (EBOV) belongs to Filoviridae family possessing single-stranded negative-sense RNA genome, which is a serious threat to human health. Nowadays, no therapeutics have been proven to be successful in efficiently decreasing the mortality rate ...
Linjin Fan   +14 more
openalex   +2 more sources

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques

open access: yesEmerging Microbes and Infections, 2022
Due to its high mortality rate and continued re-emergence, Ebolavirus disease (EVD) continues to pose a serious threat to global health. A group of viruses within the genus Ebolavirus causes this severe hemorrhagic disease in humans: Ebola virus (EBOV ...
Courtney Woolsey   +10 more
semanticscholar   +1 more source

Ebolavirus vaccines for humans and apes [PDF]

open access: yesCurrent Opinion in Virology, 2012
Because of high case fatality proportions, person-to-person transmission, and potential use in bioterrorism, the development of a vaccine against ebolavirus remains a top priority. Although no licensed vaccine or treatment against ebolavirus is currently available, progress in preclinical testing of countermeasures has been made.
Hugues Fausther-Bovendo   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy